International Journal of Advanced Multidisciplinary Research and Studies
Volume 4, Issue 4, 2024
Clinical Trials Based on Aminoglucosides Against Viral Hepatitis B and C in Oriental Kasai (Democratic Republic of Congo)
Author(s): Kazadi Hyanda Espoir, Bukasa Tshilonda Jean Christophe, Tshieyi Mubambu Willy, Musasa Tshibangu Jean Claude, Matanda Tshibangu Jean Marie, Kangudia Mukadi Gabriel, Beya Beya Laurent, Ngoyi Kadil Roger, Mbenga Kasela Leon, Ciamala Mukendi Paul
DOI: https://doi.org/10.62225/2583049X.2024.4.4.3106
Abstract:
Hepatitis A, B and C are inflammations of the liver caused by a virus. In most cases, no treatment is necessary. Depending on the type of virus, hepatitis usually clears up on its own within two to six months after infection.
The objective of the present study was to contribute to improving the health of communities suffering from viral hepatitis B and C in the population through a clinical approach based on Aminoglucosides.
Aminoglucosides are an alternative to consider in the treatment of viral hepatitis B and C because bivariate statistical analyzes have proven that there is a very significant difference between variables studied before and after treatment.
Keywords: Therapeutic Trials, Hepatitis, Aminoglucosides
Pages: 773-778
Download Full Article: Click Here